Chiome Bioscience Inc.'s market cap is currently ¥14.20B. The company's EPS TTM is ¥-22.093; its P/E ratio is ―; Chiome Bioscience Inc. is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 682.46M	¥ 630.82M	¥ 712.93M	¥ 480.85M	¥ 447.58M
Gross Profit	¥ 398.60M	¥ 348.86M	¥ 422.46M	¥ 245.27M	¥ 284.65M
Operating Income	¥ -1.21B	¥ -1.26B	¥ -1.33B	¥ -1.28B	¥ -1.40B
EBITDA	¥ -1.21B	¥ -1.24B	¥ -1.46B	¥ -1.29B	¥ -1.40B
Net Income	¥ -1.22B	¥ -1.24B	¥ -1.48B	¥ -1.29B	¥ -1.40B
Balance Sheet
Cash & Short-Term Investments	¥ 1.33B	¥ 1.73B	¥ 1.79B	¥ 2.69B	¥ 2.11B
Total Assets	¥ 1.75B	¥ 2.22B	¥ 2.34B	¥ 3.49B	¥ 2.81B
Total Debt	¥ 291.00M	¥ 184.00M	¥ 183.00M	¥ 180.00M	¥ 0.00
Net Debt	¥ -1.03B	¥ -1.54B	¥ -1.61B	¥ -2.51B	¥ -2.11B
Total Liabilities	¥ 593.73M	¥ 424.72M	¥ 446.39M	¥ 384.59M	¥ 145.13M
Stockholders' Equity	¥ 1.16B	¥ 1.79B	¥ 1.89B	¥ 3.11B	¥ 2.62B
Cash Flow
Free Cash Flow	¥ -1.07B	¥ -1.19B	¥ -1.13B	¥ -1.36B	¥ -1.54B
Operating Cash Flow	¥ -1.07B	¥ -1.19B	¥ -1.13B	¥ -1.36B	¥ -1.54B
Investing Cash Flow	¥ 173.00K	¥ 0.00	¥ -35.38M	¥ -3.52M	¥ -26.42M
Financing Cash Flow	¥ 667.30M	¥ 1.13B	¥ 271.35M	¥ 1.94B	¥ 1.34B

Currency in JPY

Chiome Bioscience Inc. Earnings and Revenue History

Income Statement >

Chiome Bioscience Inc. Debt to Assets

Balance Sheet >

Chiome Bioscience Inc. Cash Flow

Cash Flow >

Chiome Bioscience Inc. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing